| TM patients (mean ± SD) [95% CI] | Controls (mean ± SD) [95% CI] | P value |
---|---|---|---|
Males | Â | Â | Â |
RVEDVI (mL/m2) | 98.1 ± 17.3 [64.2 -- 132.0] | 88.4 ± 11.2 [66.5 -- 110.4] | 0.027 |
RVESVI (mL/m2) | 33.2 ± 8.0 [17.5 -- 48.8] | 33.8 ± 5.0 [24.0 -- 43.7] | 0.77 |
RVSVI (mL/m2) | 64.7 ± 11.2 [42.7 -- 86.6] | 54.7 ± 10.3 [34.6 -- 74.8] | 0.0015 |
RVEF (%) | 66.2 ± 4.1 [58.0 -- 74.3] | 61.6 ± 6.0 [50.0 -- 73.3] | 0.0009 |
RVMI (g/m2) | 38.8 ± 7.9 [23.3 -- 54.4] | 36.4 ± 7.8 [21.1 -- 51.7] | 0.27 |
CO (L/min) | 7.9 ± 1.9 [4.16 -- 11.5] | 6.6 ± 1.6 [3.4 -- 9.8] | 0.014 |
CI (L/min/m2) | 4.8 ± 1.0 [2.9 -- 6.7] | 3.4 ± 0.7 [2.0 -- 4.8] | <0.0001 |
Females | Â | Â | Â |
RVEDVI (mL/m2) | 86.5 ± 13.6 [59.8 -- 113.2] | 80.3 ± 12.8 [55.3 -- 105.3] | 0.093 |
RVESVI (mL/m2) | 29.2 ± 7.2 [15.1 -- 43.2] | 30.3 ± 8.6 [13.5 -- 47.1] | 0.58 |
RVSVI (mL/m2) | 57.4 ± 9.2 [39.4 -- 75.5] | 50.0 ± 7.8 [34.7 -- 65.2] | 0.0030 |
RVEF (%) | 66.3 ± 5.1 [56.4 -- 76.2] | 62.6 ± 6.4 [50.1 -- 75.0] | 0.017 |
RVMI (g/m2) | 34.0 ± 7.7 [18.8 -- 49.1] | 30.8 ± 5.3 [20.5 -- 41.1] | 0.11 |
CO (L/min) | 6.8 ± 1.7 [3.5 -- 10.1] | 5.5 ± 1.5 [2.5 -- 8.4] | 0.0033 |
CI (L/min/m2) | 4.5 ± 0.8 [2.9 -- 6.2] | 3.2 ± 0.8 [1.7 -- 4.8] | <0.0001 |